Data for Naito, 2021, Combined Use of a Polycarboxybetaine Coating and a Selective Factor XII Inhibitor Markedly Reduces Artificial Surface Clot Formation While Preserving Normal Tissue Coagulation During Extracorporeal Life Support
Published: 20 January 2021| Version 1 | DOI: 10.17632/tg8dntkgsc.1
Contributor:
Keith Cook
Description
This data is in support of our study examining the combined use of polycarboxybetaine coatings and FXII inhibition during extracorporeal life support in rabbits.
Files
Steps to reproduce
Please see paper by Naito N., Ukita R., et al.
Institutions
Carnegie Mellon University College of Engineering
Categories
Biomedical Engineering, Critical Care, Extracorporeal Membrane Oxygenation, Extracorporeal Life Support